Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Can Animal Models of Copy Number Variants That Predispose to Schizophrenia Elucidate Underlying Biology?

Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Volume of the Human Hippocampus and Clinical Response Following Electroconvulsive Therapy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. A Genetic Investigation of Sex Bias in the Prevalence of Attention-Deficit/Hyperactivity Disorder

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The Choice of Prior in Bayesian Modeling of the Information Sampling Task

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  1. Genome-wide association study implicates CHRNA2 in cannabis use disorder

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

The diagnosis of schizophrenia rests on clinical criteria that cannot be assessed in animal models. Together with absence of a clear underlying pathology and understanding of what causes schizophrenia, this has hindered development of informative animal models. However, recent large-scale genomic studies have identified copy number variants (CNVs) that confer high risk of schizophrenia and have opened a new avenue for generation of relevant animal models. Eight recurrent CNVs have reproducibly been shown to increase the risk of schizophrenia by severalfold: 22q11.2(del), 15q13.3(del), 1q21(del), 1q21(dup), NRXN1(del), 3q29(del), 7q11.23(dup), and 16p11.2(dup). Five of these CNVs have been modeled in animals, mainly mice, but also rats, flies, and zebrafish, and have been shown to recapitulate behavioral and electrophysiological aspects of schizophrenia. Here, we provide an overview of the schizophrenia-related phenotypes found in animal models of schizophrenia high-risk CNVs. We also discuss strengths and limitations of the CNV models, and how they can advance our biological understanding of mechanisms that can lead to schizophrenia and can be used to develop new and better treatments for schizophrenia.

OriginalsprogEngelsk
TidsskriftBiological Psychiatry
ISSN0006-3223
DOI
StatusUdgivet - 1 jan. 2019

ID: 55270354